This study was initiated to induce experimental autoimmune anterior uveitis (EAAU) in Lewis rats by melanin associated antigen (MAA -22 kDa fragment of type I collagen alpha 2 chain) derived from rat iris and ciliary body (CB), localize MAA within the eye and to investigate the possible mechanism of MAA generation in vivo. EAAU model replicates idiopathic human anterior uveitis (AU). Lewis rats sensitized to rat MAA developed anterior uveitis and EAAU induced by rat MAA can be adoptively transferred to naïve syngenic rats by MAA primed T cells. Animals immunized with rat MAA developed cellular immunity to the antigen. MAA was detected only in the iris and CB of the eye. Iris and CB were the major source of matrix metalloproteinase-1 (MMP-1) in the naive eye and ocular expression of MMP-1 was up-regulated while expression of tissue inhibitors of metalloproteinase 1 (TIMP1) decreased before the onset of EAAU. These results demonstrated that EAAU can be induced by autologous MAA. Uveitogenic antigen is present only in the iris and CB of the eye and the imbalance between MMP-1 and TIMP-1 may play a role in the generation of MAA in vivo. Collectively, the evidence presented here suggests that MAA is an autoantigen in EAAU. These observations may extend to idiopathic human AU and facilitate the development of antigen specific therapy.
INTRODUCTION
Uveitis is broadly defined as the inflammation of the uvea (iris, ciliary body and choroid). It is responsible for over 2.8% of blindness in the United States with a higher disease rate for the older population (1) (2) (3) . Anterior uveitis (AU) of unknown etiology is the most common form of intraocular inflammation in humans. In a nonreferal clinic approximately 52% of patients may present with idiopathic AU (1) (2) (3) . It has been considered an autoimmune disease and presents with the inflammation of the iris and/or ciliary body (CB) with no involvement of retina (1) (2) (3) . The recurrent nature of idiopathic AU results in visual complications which lead to the permanent loss of vision (1) (2) (3) . Experimental autoimmune anterior uveitis (EAAU) is an auto-immune ocular inflammatory disease that serves as a model of idiopathic human AU (4) (5) (6) (7) (8) (9) (10) (11) (12) . In this experimental model inbred Lewis rats are subcutaneously immunized in the foot-pad with melanin associated antigen (MAA) isolated from bovine iris and CB and EAAU is induced in these animals by an antigen specific CD4 + T cell response to MAA (5) (6) (7) (8) (9) (10) (11) (12) . EAAU is characterized histologically by a lymphocytic infiltration in the iris and CB (4) (5) (6) (7) (8) (9) (10) (11) (12) and antigen specific CD4 + T cells can adoptively transfer disease into naïve syngenic recipients (7, 8, 12) . EAAU can not be induced by the adoptive transfer of primed CD8 + T cells or immune sera (6) (7) (8) . MAA has been purified to homogeneity in our laboratory and our published results have shown that a 22 kDa fragment of type I collagen α2 chain [CI-α2 (22 kDa)] derived from bovine iris and CB, contains the antigenic determinant(s) necessary to induce EAAU in Lewis rats (8) .
We have previously reported that in animals immunized with bovine MAA, no inflammation was observed in retina as well as in other parts of the eye including cornea and choroid (5) (6) (7) (8) (9) (10) . Other organs such as pineal gland, liver and kidney were not affected in these animals (5) (6) (7) (8) (9) (10) . We have further demonstrated that MAA was only found in the auto-antigenic form in the iris and CB because the antigen isolated from bovine skin, bovine Achilles tendon, bovine conjunctiva, bovine gut and rat tail was not uveitogenic (8) . However, to our knowledge, induction of EAAU by rat MAA, the precise expression/localization of this uveitogenic antigen as well as the possible mechanism(s) of MAA generation in vivo has not been investigated. We initiated this study to investigate if EAAU can be induced by MAA [CI-α2 (22 kDa)] purified from rat iris and CB and to analyze the expression/localization of MAA within the rat eye. Our study was also designed to investigate the possible role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in the generation of MAA in the anterior segment of eye. MMPs are a family of zinc containing endoproteases that degrade matrix proteins and TIMPs are endogenous (natural) inhibitors of MMPs (13) . The results reported here provide evidence that MAA is the target auto-antigen in EAAU and the imbalance between the expression of MMP-1 and TIMP-1 may play a role in the generation of MAA in vivo and pathogenesis of EAAU.
EXPERIMENTAL PROCEDURES

Animals
Pathogen-free male Lewis rats (5-6 wk old) were obtained from Harlan Sprague Dawley (Indianapolis, IN). This study was approved by the Institutional Animal Care and Use Committee, University of Arkansas for Medical Sciences, Little Rock, AR.
Preparation of Melanin Associated Antigen
Melanin associated antigen -CI-α2 (22 kDa) was separately isolated from bovine iris and ciliary body (CB) as well as the iris and CB of naïve Lewis rats as previously described by us (8) . Fifty bovine and 500 rat eyes were used. Briefly, bovine iris and CB and rat iris and CB were homogenized and extracted with 0.5 M acetic acid at 45 o C for 48 hours separately. Alpha-2 chain of type I collagen was purified separately from rat and bovine iris and CB using the method described before (8) . Purified α2 chain was treated with proteolytic enzyme; Staphylococcus aureus V8 protease (Sigma, St. Louis, MO) and the 22 kDa antigen was purified using preparative SDS-PAGE and preparative Isoelectric Focusing (8) . NH 2 terminal sequence of purified rat protein was determined as previously described (8) .
Induction and evaluation of EAAU
Lewis rats were immunized with the 50 μl of stable emulsion containing 50 μg of protein (bovine or rat MAA) emulsified (1:1) in complete Freund's adjuvant (Sigma, St. Louis, MO) in the hind footpad (5) (6) (7) (8) (9) (10) (11) (12) . Animals were graded for the clinical signs of EAAU as previously described by us (5) . Eyes were harvested at various time points for histological analysis to assess the course and severity of inflammation (5) . The intensity of uveitis was histologically scored in a masked fashion on an arbitrary scale of 0-4 as follows: 0, normal; 1, dilated iris vessels plus thickened iris stroma exudates in the anterior chamber with protein or a few scattered inflammatory cells or both; 2, moderate infiltration of inflammatory cells in the stroma of the iris or CB or both and a moderate number of inflammatory cells within the anterior chamber; 3, heavy infiltration of inflammatory cells within the iris stroma and the CB and heavy infiltration of inflammatory cells within the anterior chamber; 4, heavy exudation of cells with dense protein aggregation in the anterior chamber and inflammatory cell deposits on the corneal endothelium.
Adoptive transfer of EAAU
Lewis rats were divided into two groups (n=5 animals/group). Animals in group 1 were immunized with rat MAA and the animals in group 2 were immunized with bovine MAA. Popliteal lymph nodes (LN) were harvested separately from donor rats in each group at day 14 post-immunization (7, 8) . A single-cell suspension of popliteal lymph node cells (LNCs) was made in Dulbeco's modified minimum essential medium and LNCs (20 x 10 6 ) harvested from animals in group 1 and group 2 were cultured separately with the rat and bovine antigen (20 μg/ml) respectively for 3 days. After this T cells were purified by using Cellect immunocolumns (Cytovax Biotechnologies, Inc., Canada) and were separately injected into naïve Lewis rats via the tail vein. These experiments were repeated three times with similar results.
T cell proliferation assay
At day 14 post-immunization, popliteal LN were harvested from Lewis rats immunized with rat antigen and a single cell suspension was prepared (8) . LNCs (2 x 10 5 /well) were stimulated with rat antigen (20 μg/ml) in 96-well flat bottom plates (BD Biosciences, CA). LNC obtained from Lewis rats immunized with bovine antigen and cultured in vitro with bovine antigen served as the positive control. Negative control consisted of cells cultured without antigen. Plates were cultured for 72 h at 37 o C and incubated with [ 3 H] Thymidine (1 μCi/well) (GE Healthcare Bio-Sciences Corp, Piscataway, NJ) for additional 18 hours. Stimulation index (SI; the ratio between the cpm of a culture in the presence of the antigen and the proliferation of the same cells in the absence of the antigen) was determined and a value of 3.0 and above was considered positive. These experiments were repeated three times with similar results.
Preparation of polyclonal antibodies
Purified bovine MAA (200 ng) mixed with complete Freund's adjuvant (Sigma, St. Louis, MO) was injected into New Zealand White rabbits (Charles River Laboratories, Wilmington, MA) every 10 days. Three days after the sixth injection, blood was withdrawn, serum was collected and the specificity of the antibody was determined by Western blot analysis.
Western blot analysis
Cornea, retina, iris and CB, choroid and retinal pigment epithelium (RPE) harvested from 30 eyes of naive Lewis rats were pooled separately to detect the expression of MAA. Iris and CB were collected in one tube; similarly RPE and choroid were collected together in another tube. In a separate set of experiment, intraocular tissue was prepared from the eyes harvested from naïve Lewis rats as well as Lewis rats sacrificed at different time points during EAAU. Intraocular tissues, which consisted of uvea, retina, lens, aqueous humor, and vitreous was prepared using a previously described method (14) and was used to detect protein levels of β-actin, TIMP-1, TIMP-2 and TIMP-3. Tissues prepared as described above were homogenized in 500 µl of ice-cold PBS containing protease inhibitors and 1% Nonidet P-40. The homogenate was centrifuged at 14,000 x g at 4°C for 15 min, and the supernatant was subjected to SDS-PAGE. After SDS-PAGE on a 14% linear slab gel, separated proteins were transferred to polyvinylidene difluoride membranes using a Trans-Blot semidry electrophoretic transfer cell (Bio-Rad, Hercules, CA). Western blot analysis (14) was performed using polyclonal antibodies against bovine MAA (1:1000 dilution), TIMP-1 (1: 500 dilution, R&D Systems, Minneapolis, MN), TIMP-2, and TIMP-3 (Abbiotech, San Diego, CA). Blots were also incubated with monoclonal β-actin (Mouse IgG1, Sigma, St. Louis, MO) -house keeping gene. Control blots were reacted with equivalent concentrations of normal rabbit serum or isotype matched nonspecific control antibody. After washing and incubation with HRP-conjugated appropriate secondary antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA), blots were developed using the ECL Plus Western blotting detection system (GE Healtcare Biosciences Corp, NJ). Quantification of proteins was accomplished by analyzing the intensity of the bands using Quantity One 4.2.0 (Bio-Rad). These experiments were repeated three times with similar results.
Immunohistochemistry
For frozen sections, eyes harvested from naïve Lewis rats were placed in optimal cutting temperature (OCT) compound (Electron Microscopy Sciences, Hatfield, PA) and were snap frozen. Eyes were sectioned by cryostat and the tissue (5 µm thick) was air dried over night (18 hours) , fixed in cold acetone for 10 minutes, and rehydrated in PBS (pH 7.2). Sections were stained for MAA using polyclonal antibody against bovine MAA (1:200 dilution) and immunoperoxidase staining kit from Vector Laboratories (Burlingame, CA) as described before (6) . Slides were then washed in tap water, counterstained for 10 minutes with Mayer's haematoxylin, washed thoroughly in cold tap water, and cover slipped with an aqueous mounting media for viewing by light microscopy. Control stains were performed with normal rabbit serum at the concentration similar to that of the primary antibody. Additional controls consisted of staining by omission of the primary and secondary antibody. This experiment was repeated three times with similar results.
Flow cytometry
Cornea, iris, CB, choroid, RPE and retina harvested from 18 eyes of naive Lewis rats were pooled separately. Iris and CB were collected in one tube; similarly RPE, choroid and retina were collected together in another tube. Total cells isolated from these tissues as well as from the whole rat eyes were used in flow cytometry for MMP-1, MMP-8 and MMP-13. In a parallel experiment total cells isolated for the whole eye of Lewis rats sacrificed at different time points (n=3 rats/time point) during EAAU were used in flow cytometry for MMP-1.
A single cell suspension was prepared by mashing above mentioned tissues with frosted slides followed by filtration through the cell strainer. Cells were incubated with anti-rat CD32 antibody (BD Biosciences, San Jose, CA) for 15 minutes at 4 0 C. This was followed by the intracellular stain using BD Cytoperm/Cytofix kit (BD Biosciences, San Jose, CA) according to the manufactures instructions. The cells were stained using primary antibodies for MMP-1 (Lifespan Biosciences, Seattle, WA), MMP-8 and MMP-13 (Santa Cruz Biotechnology, Santa Cruz, CA), followed by appropriate FITC or PE secondary antibodies. The stained cells were analyzed using BD FACSCalibur (BD Biosciences, San Jose, CA). These experiments were repeated three times with similar results.
Semi-quantitative RT-PCR
Cornea, iris, CB, choroid, RPE and retina harvested from 18 eyes of naive Lewis rats were pooled separately. Iris and CB were collected in one tube; similarly RPE, choroid and retina were collected together in another tube. Total RNA extracted from these tissues was used to detect mRNA levels of β-actin, MMP-1, MMP-8 and MMP-13. In a separate set of experiments Lewis rats were sacrificed at different time points (n=3 rats/time point) during EAAU and intraocular tissues, which consisted of uvea, retina, lens, aqueous humor, and vitreous was prepared using a previously described method (14) . Total RNA extracted from pooled intraocular tissues was used to detect the mRNA levels of β-actin, MMP-1, TIMP-1, TIMP-2 and TIMP-3. Total RNA was prepared using Qiagen total RNA isolation kit (Qiagen, Valencia, CA) according to the manufacturer's specifications. Semiquantitative RT-PCR was performed using the reagents purchased from BioRad. and
and 5'-GGCCCTTGCGCTGGGACAG -3' (reverse) (335 bp); Four different cycles, 25, 28, 30 and 35 were used for PCR, and all four cycles gave similar results. All reactions were normalized for β-actin expression. The negative controls consisted of the omission of RNA template or reverse transcriptase from the reaction mixture. PCR products were analyzed on a 2% agarose gel and quantitated by densitometry using Quantity One 4.2.0 (Bio-Rad). These experiments were repeated three times with similar results.
Real Time Quantitative RT-PCR
Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA). Quantitative real-time PCR (RT-qPCR) was performed using iQ TM SYBR ® Green Supermix and iQ TM 5 real time PCR unit (both purchased from Bio-Rad, Hercules, CA). The primers were designed and ordered from Integrated DNA Technologies (Coralville, IA), using the criteria provided in the Bio-Rad users manual. Primer sequences including the predicted sizes of amplified cDNA are as follows:
5'-ACATCAGGCACTCCACATCTTGGT-3'. Pilot real time RT-qPCR experiments were performed to determine optimal condition for each primer. All real-time RT-qPCR experiments were performed in duplicate. The primer specificity of the amplification product was confirmed by melting curve analysis of the reaction products using SYBR Green as well as by visualization on ethidium bromide stained agarose (1.5%) gels. The housekeeping gene β-actin was used as an internal control, and gene-specific mRNA expression was normalized against β-actin expression. iQ TM 5 optical system software version 2.0 (Bio-Rad, Hercules, CA) was used to analyze real-time RT-qPCR data and derive threshold cycle (C T ) values according to the manufacturer's instructions. The DDC T method was used to transform C T values into relative quantities with standard deviations. Same software was used to calculate the normalized expression of the gene of interest, using β-actin as reference gene and the results were expressed as normalized fold expression.
Cleavage of rat type I collagen by MMP-1
Human MMP-1 (Millipore, Billerica, CA) was activated with trypsin for 10 min at 25 °C, and the trypsin was inactivated with 10-fold excess soybean trypsin inhibitor. Rat type I collagen was incubated with activated human MMP-1 for 26 h at 25 °C and the reaction was stopped by the addition of EDTA to a final concentration of 50 mM. Digestion products were resolved on 12% SDS-PAGE and the gel was stained with Coomassie Blue to assess the cleavage of rat type I collagen by activated MMP-1.
Statistical analysis
The data are expressed as the mean ± SD. Data were analyzed and compared using the Student's t-test, and differences were considered statistically significant with p < 0.05. (22 kDa)] . In this study α-2 chain of type I collagen was purified from the iris and the ciliary body (CB) harvested from the eye of naïve Lewis rats. Purified α-2 chain of type I collagen was then digested with V8 protease and the 22 kDa fragment of type I collagen α2 chain [CI-α2 (22 kDa) -MAA] was purified as previously described by us (8) . The N-terminal composition of the purified rat antigen is given in Table 1 . Amino acid sequence alignment revealed 97.3% homology with the 22 kDa fragment of type I collagen α2 chain isolated from bovine iris and CB (Table 1 ). Further analysis of the primary structure of rat type I collagen α-2 chain (PDB ID: ly0f) demonstrated the localization of MAA in rat type I collagen α-2 chain ( Figure 1A ). This structural analysis was performed using the UCSF Chimera software for molecular modeling (15) . Next we examined the ability of rat CI-α2 (22 kDa) to induce EAAU in Lewis rats. Animals were divided into two groups and animals in group 1 (n=20 animals) were immunized with bovine antigen (22 kDa protein), whereas animal in group 2 (n=10 animals) were immunized with 22 kDa rat antigen. In agreement with our previous report (8) immunization with pure bovine antigen (22 kDa protein) induced severe uveitis in both eyes of all twenty Lewis rats in group 1 (Table 2, Figure 1 , B and D). Interestingly, the disease induced in Lewis rats by rat antigen was similar to the EAAU induced in Lewis rats by bovine antigen ( Table 2 ). All ten animals immunized with pure 22 kDa protein isolated from rat iris and CB developed EAAU in both eyes (Table 2, Figure 1 B-C) . However, the clinical and histopathological examination revealed that the pathogenic antigen isolated from rat iris and CB (Figure 1 B-C) was less uveitogenic than bovine antigen (Figure 1 B-D ). The cornea (Figure 1 C-D) , retina and choroid (data not shown) were not affected in these animals. EAAU did not develop in control animals injected with adjuvant alone (Table 2, Figure 1E ). Intact α-2 chain of type I collagen purified from rat iris and ciliary body (emulsified in complete Freund's adjuvant) did not induce EAAU ( Table 2) . None of the animals immunized with purified rat or bovine MAA [CI-α2 (22 kDa)] manifested clinical signs of arthritis (data not shown).
RESULTS
Induction of EAAU by rat MAA [CI-α2
Adoptive transfer of rat MAA [CI-α2 (22 kDa)] induced EAAU.
Adoptive transfer experiments with in vitro primed antigen specific T cells were used to test the ability of rat MAA to transfer EAAU to naïve syngenic rats. A singlecell suspension of popliteal lymph node cells (LNCs) harvested from Lewis rats that were immunized with rat antigen was cultured with the rat antigen for 3 days. In parallel, a single-cell suspension of popliteal LNCs harvested from Lewis rats immunized with bovine antigen was cultured with bovine antigen and served as the positive control. Our data show that ten million T cells isolated from the draining LN of Lewis rats immunized with purified rat antigen transferred EAAU to naive syngenic rats (Table 3, Figure 2 ). The disease started at day 9 after cell transfer and remained active for 4 days. However, the disease activity of EAAU in these animals was less severe (Figure 2A ) than EAAU observed in the animals receiving same number of T cells from donor rats immunized with bovine antigen ( Figure 2B ) and these differences were statistically significant (Table 3) . Thus, by adoptive transfer experiments we demonstrated that EAAU induced by rat MAA is also a T cell mediated auto-immune disease.
Immunogenecity of rat MAA [CI-α2 (22 kDa) ]. We have previously reported that EAAU induced by bovine MAA could not be adoptively transferred by immune sera (7). Furthermore, animals immunized with bovine MAA developed antibodies to this antigen, but there was no correlation between humoral immune response and disease activity in EAAU (8) . Therefore, in the current study cellular response to rat MAA was investigated using an in vitro lymphocyte proliferation assay. Popliteal lymph nodes were harvested from Lewis rats that were immunized with rat MAA or bovine MAA and single cell suspension of LNCs was cultured separately for 72 hours. LNCs from rat MAA immunized animals were cultured in the presence or absence of rat MAA. Similarly the LNCs from bovine MAA immunized animals were cultured in presence or absence of bovine MAA. Our data presented in Figure 3 demonstrated that LNCs from rats challenged with rat antigen elicited a proliferative lymphocyte response (SI =28.6 ± 3.2). However, this proliferative response (Figure 3) was significantly (P<0.05) less than the proliferative response observed when LNCs harvested from Lewis rats immunized with bovine antigen were treated in vitro with the bovine antigen (SI = 39.2 ± 2.9). LNCs from animals sensitized with rat MAA or bovine MAA failed to proliferate in vitro in the absence of the antigen (Figure 3) .
Localization of MAA [CI-α2 (22 kDa) ] in the Rat Eye. Since in animals with EAAU the inflammation is observed only in the iris and CB of the eye, (5-12) we next asked if MAA was only present within the iris and CB or it is expressed in other parts of the eye also. Extraction of MAA from Lewis rat eye is time consuming and cost intensive. Five hundred rat vs fifty bovine eyes were required for the similar recovery (~ 1.0 mg) of the purified protein (MAA).
Therefore, polyclonal antibodies used for MAA localization studies were raised against bovine antigen only. b) Immunohistochemical Analysis Immunohistochemistry using frozen sections of the eye harvested from naïve Lewis rats was performed to confirm that MAA -CI-α2 (22 kDa) is present within the iris and CB of the rat eye. Staining was observed on the iris and CB when anti-MAA antibody was used ( Figure 4B ). MAA was not detected on the cornea (Figure 4B) , lens, retina, RPE and choroid (data not shown). No staining was detected in the sections stained with equivalent dilution of normal rabbit serum ( Figure  4C ). Taken Figure 5A , lane 3) of the naïve rat eye. The real time RT-qPCR analysis further confirmed the higher expression of MMP-1 mRNA in iris and CB of naïve rat eye compared to extremely low levels of MMP-1 in cornea and RPE-retinachoroid ( Figure 5B ). We were not able to detect MMP-8 and MMP-13 transcripts in these samples by real time RT-qPCR. Similar pattern was observed for MMP-1 protein (present intracellularly) as determined by flow cytometric analysis ( Figure 5C ). Interestingly, MMP-8 and MMP-13 transcripts ( Figure 5A ) and protein ( Figure 5 , D and E) could not be detected in these samples. Taken together our results established that MMP-1 is constitutively expressed in the iris and CB of naïve rat eye.
Since MMP-1 cleavage site is present on the α-2 chain of rat type I collagen ( Figure 1A) , we investigated if rat type I collagen can be cleaved by activated MMP-1 in vitro. Our data presented in Figure 5F demonstrates that MMP-1 cleaved α1 and α2 chains of rat type I collagen efficiently into classical ¾ and ¼ fragments along with several other collagen peptides of different sizes (lane 2). It is of interest to note that some of these collagen peptides were present between 20-25 kDa ( Figure 5F , lane 2) and the molecular mass of MAA is 22 kDa. No cleavage of α1 and α2 chains of rat type I collagen was observed in the absence of activated MMP-1 ( Figure 5F, lane 1) .
b) Ocular expression of MMP-1during EAAU. Since only MMP-1 could be detected in the iris and CB of the normal rat eye we investigated the expression profile of MMP-1 in the eyes of Lewis rats during the course of EAAU. Lewis rats immunized with bovine MAA were sacrificed at day 11, 14, 19, 23 and 30 postimmunization and the expression of MMP-1 transcripts and protein was assessed by semiquantitative RT-PCR and flow cytometric analysis respectively.
In MAA-sensitized animals, a substantial increase in MMP-1 mRNA was observed at day 11 post-immunization (before the onset of EAAU) compared with naive animals (Figure 6 A-B) . MMP-1 transcripts were further upregulated at day 14 (the onset of EAAU) but declined at day 19 (the peak of EAAU). As shown in Figure 6 A and B the expression of MMP-1 transcripts further decreased during the resolution (day 23) and after the resolution of EAAU (day 30). These results were further confirmed by including day 12 postimmunization as an additional day and using real time RT-qPCR. Similar to day 11, low levels of MMP-1 transcripts were detected at day 12 also (Figure 6C ). The pattern of MMP-1 mRNA expression during EAAU detected by real time RT-qPCR ( Figure 6C ) was similar to that observed with semi-quantitative RT-PCR (Figure 6 A-B) . Similar pattern for MMP-1 + cells in the eye was observed by flow cytometric analysis during the course of EAAU ( Figure 6F ). MMP-1 + cells increased significantly on day 11 and 14 postimmunization in the eyes of rats with EAAU compared to naïve rats (p< 0.05, Figure 6F ). The levels of MMP-1 expressing cells declined on days 19 -30 ( Figure 6F (both mRNA and protein) was observed on day 14 (the onset of EAAU) followed by decreased levels TIMP-1 on day 19, 23 and 30 ( Figure 6A , D, E, G, H) in these animals. In contrast, both mRNA and protein levels of TIMP-2 and TIMP-3 did not change during the course of EAAU and were similar to those observed in the eye of naïve Lewis rats (data not shown). Since TIMP-1 mRNA expression decreased drastically at day 11, we confirmed these results by performing real time qRT-PCR for TIMP-1 transcripts at different time points including an additional time point of day 12 post-immunization. Our results revealed that similar to day 11, TIMP-1 mRNA expression was down-regulated at day 12 post-immunization also ( Figure 6E ).
DISCUSSION
Experimental autoimmune anterior uveitis (EAAU) is an organ specific inflammatory disease that affects the iris and the ciliary body (CB) of the eye and serves as an animal model of human idiopathic anterior uveitis (4) (5) (6) (7) (8) (9) (10) (11) (12) . In the present study we have purified a 22 kDa fragment of type I collagen α-2 chain [CI-α2 (22 kDa)] from the iris and CB of Lewis rats and have demonstrated that this protein can induce EAAU in Lewis rats. We have determined that the uveitogenic antigen is solely localized to the iris and the CB of the rat eye and have addressed a possible mechanism of auto-antigen generation in vivo. Our previous work has shown that the pathogenic antigen in EAAU is a 22 kDa fragment of type I collagen α2 chain associated with bovine uveal melanin (8) and referred it to as melanin associated antigen (MAA) (5) (6) (7) (8) (9) (10) (11) (12) . Melanin pigment is synthesized within the melanocytes, and deposited on a proteinaceous matrix structure, called melanosomes (16) . Biologic melanin contains several matrix proteins, which are bound to the chromophoric backbone during polymer formation (16, 17) . Although Lewis rat is amelanotic (i.e. no melanin is present) animal, the melanocytes with premelanosomes and matrix proteins are present within the eye of this animal (18) . Results from the present study demonstrated that the uveitogenic antigen purified from Lewis rat iris and CB is also a 22 kDa fragment of type I collagen α2 chain. Therefore, in order to be consistent with our previous publications (5) (6) (7) (8) (9) (10) (11) (12) , EAAU causing antigen [CI-α2 (22 kDa)] purified from Lewis rat eye is also referred as MAA in the current manuscript.
Our results have shown that the clinical and histopathologic pattern of EAAU induced by rat MAA are similar to that induced by bovine MAA. However, the severity of disease with rat antigen was less than that observed with the bovine antigen when EAAU was induced by active immunization or by adoptive transfer of antigen specific T cells. Furthermore, lymph node cells from rat MAA sensitized Lewis rats demonstrated a proliferative response that was less than the proliferative response observed with lymph node cells harvested from bovine MAA sensitized animals. These differences in the pathogenecity may arise from the differences in the primary structure (i.e. amino acids) as well as glycosylation pattern of rat and bovine MAA. The present study revealed a 97.3% sequence homology at the amino acid level between amino terminal region of purified rat and bovine MAA. Additionally, we have previously reported that bovine MAA [CI-α2 (22 kDa)] was pathogenic only if bound carbohydrates were intact and carbohydrate moieties bound to the antigen were crucial to the pathogenecity (8) . Type I collagen contains covalently attached carbohydrate units; the nature and the number of carbohydrate units per collagen molecule varies among different species (19, 20) . Previous studies using experimental autoimmune uveoretinits (EAU) model have shown that heterologous antigen is more potent than the homologous antigen with higher level of T cell responsiveness to the heterologous antigens (21, 22) .
The data presented in the current manuscript provide a direct correlation between the site of inflammation in EAAU and constitutive expression of MAA in Lewis rat eye. Results from our study demonstrated that the 22 kDa MAA was specifically present in the iris and CB of naïve Lewis rat eye.
Since MAA is endogenously expressed only on the iris and CB of the rat eye, its recognition by T cells is most likely responsible for inflammation of these ocular tissues during EAAU.
Type I collagen is a major component of the anterior uveal tract i.e. the iris and CB (23) . We have previously reported that intact α-1 and α-2 chains of bovine iris and CB derived type I collagen are not uveitogenic (8) . Interestingly, our published data (8) and the results presented in this manuscript clearly demonstrate that Lewis rats developed EAAU only if the α-2 chain of type I collagen (purified from bovine and rat iris & CB) underwent proteolysis. These observations suggest that the proteolytic degradation of the α-2 chain led to the exposure of an antigenic epitope(s) that is necessary to induce uveitis in Lewis rats. To explore this possibility we focused our attention on defining ocular microenvironment in which MAA may be generated and/or exposed in vivo and hypothesized that tissue specific matrix metalloproteases (MMPs) may mediate the fragmentation of type I collagen present in the iris and CB of the eye. Generation of an auto-antigen by MMPs has been reported in the literature (24, 25) .
We specifically analyzed the expression of MMP-1 (collagenase 1), MMP-8 (collagenase 2) and MMP-13 (collagenase 3) in the naïve rat eyes as well as in the eyes during EAAU. Our results clearly demonstrated that iris and CB were the major source of MMP-1 in the naive rat eye. It has been reported that in the human eye MMP-1 is present in significantly higher amount in iris and CB compared to other ocular tissues and may play an important role in the normal turnover of matrix proteins (26) .
We were unable to detect MMP-8 and MMP-13 in the rat eye. Together these results suggested that MMP-1 constitutively expressed in the iris and CB of the eye of naïve rat may participate in the generation and/or exposure of MAA which may otherwise be masked in the triple helix of type I collagen. It is known that MMP-1 exhibits specificity for type I collagen. MMP-1 first unwinds the helical collagen molecule before preferentially binding to and cleaving the α2 chain of type I collagen (27) . Importantly, our present and past (8) studies demonstrated that MAA is a 22 kDa fragment of type I collagen α2 chain and molecular modeling using the UCSF Chimera software (15) revealed the presence MMP-1 cleavage on the α-2 chain of type I collagen. Additionally, in the present study we observed that MMP-1 can cleave rat type I collagen in vitro, into classical ¾ and ¼ fragments along with several collagen peptides of different sizes including collagen fragments between 20-25 kDa. These results are in agreement with those reported in the literature (28) (29) (30) .
The presence of MMP-1 in the iris and CB may have pathologic significance in EAAU. Upregulation of MMP-1 simultaneous with decreased expression of its natural inhibitor -TIMP-1 before the onset of EAAU as observed in our study will lead to accelerated generation of MAA in vivo. This may be needed for the propagation of the auto-immune response which drives EAAU. On the other hand, up-regulation of TIMP-1 at the onset of auto-immune uveitis may have a protective effect in EAAU as it will counteract the activity of up-regulated MMP-1 and prevent further generation of MAA. Increased levels of MMP-1 and TIMP-1 observed at the onset of EAAU may be in part due to tumor necrosis factor-alpha (TNF-α). Our published study has shown that the levels of TNF-α increased at the onset of EAAU (12) . Inflammatory cytokines such as TNF-α have been reported to augment the expression of MMPs and TIMPs (31, 32) . Our results that the levels of MMP-1 were up-regulated before the onset of EAAU when no inflammatory cells could be detected in the eye (5) (6) (7) (8) (9) (10) (11) (12) and decreased moderately at the peak of EAAU when there is a massive infiltration of the inflammatory cells in the anterior segment of the eye (5) (6) (7) (8) (9) (10) (11) (12) suggest that the expression of MMP-1 originated mainly from the iris and CB of the eye. However, invading inflammatory cells will also have some contribution towards MMP-1 expression observed during EAAU because MMP-1 is expressed on a wide variety of cell types including T cells (12) .
In conclusion, we report three novel observations in this manuscript. First EAAU can be induced by a fragment of rat type I collagen, second that the pathogenic antigen is present only in the iris and CB of the eye and third the generation and/or exposure of MAA [CI-α2 (22kDa)] by MMP-1 as a possible mechanism of autoantigen generation in vivo. Furthermore, our results suggest that regulation of MMP-1 by TIMP-1 may play an important role in the pathogenesis of autoimmune uveitis. A tight balance has been reported to exist between the levels of MMPs and TIMPs under normal conditions (13) and alteration of the balance between MMPs and TIMPs has been implicated in the pathogenesis of various diseases (33) (34) (35) . Many autoantigens are not generated from rare molecules, but from common and abundant proteins. In organ specific autoimmune diseases autoreactivity against ubiquitous antigen develops, but the disease is restricted to a particular organ presumably due to greater accessibility and/or amount of the autoantigen in the target organ (36) (37) (38) . Type I collagen is the most abundant protein in mammals (39) .
Collectively, the findings reported in the current manuscript establish an etiologic role for MAA [CI-α2 (22kDa)] in EAAU with broader implications to human idiopathic anterior uveitis (AU). It is possible that idiopathic human AU may also be the result of an autoimmune response to fragment(s) of type I collagen confined to the anterior segment of the eye. Human AU has been historically characterized as a collagen disease (40) . Idiopathic human AU and its complications lead to permanent loss of vision and due to unknown etiology the disease can only be treated symptomatically. Precise identification of MAA [CI-α2 (22kDa)] as the autoantigen and understanding the possible mechanism by which uveitogenic antigen is generated in vivo is crucial to elucidate the etiopathogenesis of idiopathic AU and may lead to the development of effective and safe antigen specific therapies. Currently nonspecific therapies such as steroid and immunosuppressive agents are used to treat the patients with idiopathic AU and these treatment modalities are associated with serious side effects (1-3). 
